, Tracking Stock Market Picks
Enter Symbol:
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

up 167.54 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Buy with price target $205 by Deutsche Bank

Posted on: Monday,  Feb 10, 2014  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 02/10/2014. Previously Deutsche Bank rated Buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on
09/28/2011., when the stock price was $67.21. Since then, Alexion Pharmaceuticals, Inc. has gained 167.55% as of 12/11/2015's recent price of $179.82.
If you would have followed the previous Deutsche Bank's recommendation on ALXN, you would have gained 167.54% of your investment in 1535 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2014 1:25 PM Buy
169.67 205.00
as of 10/17/2014
1 Week down  -1.81 %
1 Month up  1.99 %
3 Months up  6.24 %
1 YTD up  23.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2011 8:25 AM Buy
67.21 78.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy